Among the farmers, labourers, religious zealots and political refugees who washed up on the shores of British-controlled Palestine during the inter-war period was German architect Erich Mendelsohn. Fleeing the rise of Nazism, Mendelsohn landed in the Levant in 1934, leaving behind a decade’s worth of prominent commissions in both Germany and Britain.
In Palestine, then a country in the making, Mendelsohn found an unblemished canvas on which he could inscribe an evolving aesthetic as much informed by his sophisticated past as by his idealistic visions for the nation’s future. Emboldened by the potential of this desert utopia and lauded by its nascent intellectual class, the modernist Mendelsohn unabashedly enthroned himself as Palestine’s chief architect. ‘Palestine of today symbolises a union between the most modern civilisation and a most antique culture,’ he wrote. ‘It is the place where intellect, vision, matter and spirit meet.’
December 12, 2018
According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime. In a study published in Cell Reports, researchers at the Weizmann Institute of Science have revealed a previously unknown mechanism underlying anxiety. Targeting this biochemical pathway may help develop new therapies to alleviate the symptoms of anxiety disorders.
December 11, 2018
Four of the Institute’s newest recruits—Drs. Amir Abboud, Yaron Antebi, Noam Tal Hod, and Sergey Semenov—kick off this review of the Weizmann Institute’s phenomenal progress in 2018. They lead us into the David Lopatie Conference Centre, where we’re introduced to other new faculty members who came aboard this year: Drs. Moran Shalev-Benami, Naama Kanarek, Filipe Natalio, Serge Rosenblum, Sivan Refaely Abramson, Giora Alexandron, and Yael Kiro.
In an effort to advance basic research insights for the benefit of therapeutic discoveries, the Weizmann Institute of Science is establishing the Dr. Barry Sherman Institute for Medicinal Chemistry, thanks to a major gift from the Sherman family.
December 10, 2018
Cancer arises when cells lose control. Deciphering the “blueprint” of cancer cells – outlining how cancer cells hijack specific pathways for uncontrolled proliferation – will lead to more efficient ways to fight it. Now, in a joint effort, scientists from the Weizmann Institute of Science and clinicians from major hemato-oncology departments in Israel have successfully created detailed profiles of myeloma cancer in both pre-cancer stages, in newly diagnosed multiple myeloma patients, as well as post-treatment and relapse. These detailed blueprints will help in future precision diagnosis and treatment of this disease.
December 06, 2018
Horizon, the EU Research & Innovation Magazine, reports on a breakthrough by Dr. Liran Shlush in diagnosing AML, a form of leukemia that is typically diagnosed at a late stage. Shlush has found a way to predict AML long before symptoms appear.
December 04, 2018
At its 70th annual International Board Meeting, the Weizmann Institute of Science conferred the degree of Doctor of Philosophy honoris causa upon longtime supporter and leader Ellen Merlo. The Weizmann Institute of Science, located in Rehovot, Israel, is one of the world’s leading centers of multidisciplinary scientific research.
December 04, 2018
JEM interviews Prof. Eran Elinav, whose microbiome research has transformed the way we think about diet, nutrition, probiotics, and more.
November 30, 2018
On November 29, 2018, American Committee supporters from across the U.S. tuned in for new CEO Dave Doneson’s first video conference, “Weizmann Science: Why Basic Research Matters and Merits Our Support.” In conversation with Bonnie Diamond, Senior Vice President of Donor Relations & National Programs, Mr. Doneson illustrated the value of basic science by sharing the stories of three transformative breakthroughs.
November 29, 2018
©2019 American Committee for the Weizmann Institute of Science
